Priapism associated with iloperidone: A case report

General Hospital Psychiatry

Volumn 36, Issue 4, 2014, Pages 451.e5-451.e6

  Rodriguez Cabezas, Lisette A ^a   Kong, Betty Y ^a   Agarwal, Gaurava ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Antipsychotics; Bipolar; Iloperidone; Priapism; Psychosis

Indexed keywords

ARIPIPRAZOLE; ILOPERIDONE; LITHIUM; LURASIDONE; PAROXETINE; ISOXAZOLE DERIVATIVE; NEUROLEPTIC AGENT; PIPERIDINE DERIVATIVE;

ADULT; AGITATION; ARTICLE; BIPOLAR I DISORDER; CASE REPORT; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; HUMAN; IRRITABILITY; MALE; MANIA; PAINFUL ERECTION; PRIAPISM; PSYCHOSIS; RISK ASSESSMENT; SLEEP DISORDER; BIPOLAR DISORDER; CHEMICALLY INDUCED;

ADULT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; HUMANS; ISOXAZOLES; MALE; PIPERIDINES; PRIAPISM;

EID: 84902824743     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2014.03.011     Document Type: Article

References (15)

1. Montague D.K., Jarow J., Broderick G.A., Dmochowski R.R., Heaton J.P., Lue T.F., et al. American Urological Association guideline on the management of priapism. J Urol 2003, 170:1318-1324.
2. El-Bahnasawy M.S., Dawood A., Farouk A. Low-flow priapism: risk factors for erectile dysfunction. BJU Int 2002, 89:285-290.
3. Salonia A., Eardley I., Giuliano F., Hatzichristou D., Moncada I., Vardi Y., et al. European Association of Urology guidelines on priapism. Eur Urol 2014, 65:480-489.
4. Broderick G.A., Kadioglu A., Bivalacqua T.J., Ghanem H., Nehra A., Shamloul R. Priapism: pathogenesis, epidemiology, and management. J Sex Med 2010, 7:476-500.
5. Sood S., James W., Bailon M.J. Priapism associated with atypical antipsychotic medications: a review. Int Clin Psychopharmacol 2008, 23:9-17.
6. Andersohn F., Schmedt N., Weinmann S., Willich S.N., Garbe E. Priapism associated with antipsychotics: role of alpha1 adrenoceptor affinity. J Clin Psychopharmacol 2010, 30:68-71.
7. Richelson E., Souder T. Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci 2000, 68:29-39.
8. Vanda Pharmaceuticals I. Fanapt (iloperidone) package insert. Rockville, MD 2013.
9. Iloperidone (Fanapt) - another second-generation antipsychotic. Med Lett Drugs Ther 2010, 52:13-14. [quiz 17].
10. Ereshefsky L., Riesenman C., Lam Y.W. Antidepressant drug interactions and the cytochrome P450 system. The role of cytochrome P450 2D6. Clin Pharmacokinet 1995, 29(Suppl. 1):10-18. [discussion 18-9].
11. Citrome L. Iloperidone: chemistry, pharmacodynamics, pharmacokinetics and metabolism, clinical efficacy, safety and tolerability, regulatory affairs, and an opinion. Expert Opin Drug Metab Toxicol 2010, 6:1551-1564.
12. Clinical pharmacology [database online] 2013, Gold Standard, Inc., Tampa, FL.
13. Weiden P.J. Iloperidone for the treatment of schizophrenia: an updated clinical review. Clin Schizophr Relat Psychoses 2012, 6:34-44.
14. du Toit R.M., Millson R.C., Heaton J.P., Adams M.A. Priapism. Can J Psychiatry 2004, 49:868-869.
15. Paklet L., Abe A.M., Olajide D. Priapism associated with risperidone: a case report, literature review and review of the South London and Maudsley hospital patients' database. Ther Adv Psychopharmacol 2013, 3:3-13.